| Ytd | 11.07% | |
| 1y | -38.82% |
| Open | 3.00 | Prev Close | 3.02 | Low | 2.95 | High | 3.05 | Mkt Cap | 1.05B |
| Vol | 71.89K | Avg Vol | 1.46M | EPS | 0.33 | P/E | 9.15 | Forward P/E | 5.44 |
| Beta | 1.60 | Short Ratio | 5.09 | Inst. Own | 56.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 2.81 | 200-d Avg | 2.74 | 1yr Est | 3.18 |
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Compan
GoodRx (GDRX) might move higher on growing optimism about its earnings prospects, which is reflected
Investors interested in Medical Services stocks are likely familiar with GoodRx Holdings, Inc. (GDRX
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today launched [ur
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription
You turn 65, sign up for Medicare, and a wall of mail arrives pushing standalone Part D drug plans.
GoodRx Holdings, Inc. faces ongoing revenue and margin pressure as its legacy business declines and
Cramer recommends buying Chevron (CVX) due to good cash flow and limited downside, and waiting to bu
GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript
Out-of-pocket drug costs are rising for millions of Americans. Coverage gaps are widening.
OptimizeRx nears Q1 earnings amid declining revenue forecasts, softer trends and a cautious outlook,
The headline numbers for GoodRx (GDRX) give insight into how the company performed in the quarter en
GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.07 per share, in line with the Z
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “Goo
GoodRx (NASDAQ:GDRX), the leading platform for prescription savings in the U.S., today announced tha
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription
HIMS broadens digital-first care with Novo Nordisk GLP-1 access, new cancer detection and Labs tools
OPRX edges past GDRX with AI-driven platform momentum, stronger estimates and lower valuation despit
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Compan
• GoodRx Holdings shares are advancing steadily. What's driving GDRX shares up?
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription
Sentiment Change Creates Opportunity
Novo Nordisk launches Wegovy weight loss pill in the US, showing up to 17% weight loss, with prices
Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prep
During Monday's session, 402 companies made new 52-week lows.
On Thursday, 930 stocks hit new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 o
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report
Companies Reporting Before The Bell • Celsius Holdings (NASDAQ:CELH) is estimated to report quar